Coping as a predictor of treatment outcome in people at clinical high risk of psychosis

被引:21
|
作者
Kommescher, Mareike [1 ]
Wagner, Michael [2 ]
Puetzfeld, Verena [1 ]
Berning, Julia [2 ]
Janssen, Birgit [3 ]
Decker, Petra [4 ]
Bottlender, Ronald [4 ]
Moeller, Hans-Juergen [4 ]
Gaebel, Wolfgang [3 ]
Maier, Wolfgang [2 ]
Klosterkoetter, Joachim [1 ]
Bechdolf, Andreas [1 ]
机构
[1] Univ Cologne, Dept Psychiat & Psychotherapy, D-50924 Cologne, Germany
[2] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany
[3] Univ Dusseldorf, Dept Psychiat & Psychotherapy, Dusseldorf, Germany
[4] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany
关键词
cognitive behaviour therapy; coping; early intervention; predictor; psychosis prodrome; ULTRA-HIGH-RISK; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; OBSTETRIC COMPLICATIONS; SCHIZOPHRENIC-PATIENTS; 1ST-EPISODE PSYCHOSIS; PSYCHOLOGICAL THERAPY; STRATEGIES; SYMPTOMS; METAANALYSIS;
D O I
10.1111/eip.12130
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
AimThe concept of coping is relevant to recent models of psychosis, and people with established psychotic disorders have been found to predominately use maladaptive coping strategies. This study aimed to examine the general coping patterns of people at clinical high risk of psychosis (CHR) and to investigate whether pre-therapy coping behaviour plays a role in predicting responsiveness to early interventions. MethodsOne hundred twenty-eight help-seeking CHR outpatients were randomized into two treatment groups: either receiving integrated psychological intervention (IPI), including cognitive behaviour therapy, or supportive counselling (SC) for 12 months. Of those, 91 persons completed a Stress Coping Questionnaire (SCQ) at intake: 45 in the IPI group and 46 in the SC group. General coping behaviour in this sample was analysed and several regressions were conducted separately for each treatment group to examine coping as a predictor of outcome after 12 months of different forms of treatment. ResultsParticipants relied significantly more on negative than on positive coping strategies, t(90)=-7.185, P<0.001, and within the positive strategies, stress control was the most preferred one, t(90)=10.979, P<0.001. Several pre-therapy coping strategies significantly predicted improvement in symptomatic outcome in both treatment groups, explaining between 16% and 25% of variance. The predictive value of coping was higher in the SC group. ConclusionsMaladaptive coping behaviours were found to emerge in the early stages of psychosis and coping behaviour contributed significantly to the prediction of post-treatment symptom improvement. These findings indicate a need for psychosocial support and coping strategy enhancement in people at risk of psychosis.
引用
收藏
页码:17 / 27
页数:11
相关论文
共 50 条
  • [21] Effects of cannabidiol on symptoms in people at clinical high risk for psychosis
    Bhattacharyya, Sagnik
    Appiah-Kusi, Elizabeth
    Wilson, Robin
    O'Neill, Aisling
    Brammer, Michael
    Williams, Steven
    Perez, Jesus
    Bossong, Matthijs G.
    McGuire, Philip
    [J]. WORLD PSYCHIATRY, 2024, 23 (03) : 451 - 452
  • [22] Substance use in people at clinical high-risk for psychosis
    Russo, Debra A.
    Stochl, Jan
    Painter, Michelle
    Jones, Peter B.
    Perez, Jesus
    [J]. BMC PSYCHIATRY, 2014, 14
  • [23] Physical Health and Transition to Psychosis in People at Clinical High Risk
    De Micheli, Andrea
    Provenzani, Umberto
    Krakowski, Kamil
    Oliver, Dominic
    Damiani, Stefano
    Brondino, Natascia
    Mcguire, Philip
    Fusar-Poli, Paolo
    [J]. BIOMEDICINES, 2024, 12 (03)
  • [24] Cognitive remediation in young people at clinical high risk of psychosis
    Piskulic, Danijela
    Barbato, Mariapaola
    Addington, Jean
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 : 89 - 89
  • [25] Substance use in people at clinical high-risk for psychosis
    Debra A Russo
    Jan Stochl
    Michelle Painter
    Peter B Jones
    Jesus Perez
    [J]. BMC Psychiatry, 14
  • [26] Neurochemical effects of oxytocin in people at clinical high risk for psychosis
    Davies, Cathy
    Rutigliano, Grazia
    De Micheli, Andrea
    Stone, James M.
    Ramella-Cravaro, Valentina
    Provenzani, Umberto
    Cappucciati, Marco
    Scutt, Eleanor
    Paloyelis, Yannis
    Oliver, Dominic
    Murguia, Silvia
    Zelaya, Fernando
    Allen, Paul
    Shergill, Sukhi
    Morrison, Paul
    Williams, Steve
    Taylor, David
    Lythgoe, David J.
    McGuire, Philip
    Fusar-Poli, Paolo
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (05) : 601 - 615
  • [27] MALADAPTIVE SCHEMAS IN YOUNG PEOPLE AT CLINICAL HIGH RISK FOR PSYCHOSIS
    Stowkowy, Jacqueline
    Addington, Jean
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 282 - 283
  • [28] Prediction of Functional Outcome in Individuals at Clinical High Risk for Psychosis
    Carrion, Ricardo E.
    McLaughlin, Danielle
    Goldberg, Terry E.
    Auther, Andrea M.
    Olsen, Ruth H.
    Olvet, Doreen M.
    Correll, Christoph U.
    Cornblatt, Barbara A.
    [J]. JAMA PSYCHIATRY, 2013, 70 (11) : 1133 - 1142
  • [29] Treatment outcomes for young people at clinical high risk for psychosis: Data from a specialized clinic
    West, Michelle L.
    Parrish, Emma M.
    Friedman-Yakoobian, Michelle
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2022, 16 (05) : 500 - 508
  • [30] Coping Strategies and Their Relationship to Psychopathologies in People at Ultra High-Risk for Psychosis and With Schizophrenia
    Lee, Su Young
    Kim, Kyung Ran
    Park, Jin Young
    Park, Jong Suk
    Kim, Bora
    Kang, Jee In
    Lee, Eun
    An, Suk Kyoon
    Kwon, Jun Soo
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 2011, 199 (02) : 106 - 110